Connection

Alireza Zali to Inflammatory Bowel Diseases

This is a "connection" page, showing publications Alireza Zali has written about Inflammatory Bowel Diseases.
Connection Strength

1.141
  1. V617F-independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease. J Cell Biochem. 2019 09; 120(9):15746-15755.
    View in: PubMed
    Score: 0.226
  2. Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases. Microb Pathog. 2018 Apr; 117:285-289.
    View in: PubMed
    Score: 0.208
  3. Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease. Anaerobe. 2018 Apr; 50:93-100.
    View in: PubMed
    Score: 0.207
  4. Distribution and phylogenetic analysis of Blastocystis sp. subtypes isolated from IBD patients and healthy individuals in Iran. Eur J Clin Microbiol Infect Dis. 2017 Dec; 36(12):2335-2342.
    View in: PubMed
    Score: 0.199
  5. The first study on opportunistic intestinal microsporidiosis in IBD patients receiving immunosuppressive medications in Iran. Epidemiol Infect. 2017 07; 145(10):2095-2099.
    View in: PubMed
    Score: 0.197
  6. The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells-conditioned medium in chronic colitis. J Cell Physiol. 2018 11; 233(11):8754-8766.
    View in: PubMed
    Score: 0.053
  7. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. Int Immunopharmacol. 2018 Jan; 54:86-94.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.